Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era
- Authors: Anne Schuchat1, Amy Parker Fiebelkorn2, William Bellini3
- Editors: W. Michael Scheld4, James M. Hughes5, Richard J. Whitley6
-
VIEW AFFILIATIONS HIDE AFFILIATIONSAffiliations: 1: The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329; 2: Division of Viral Diseases, The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329; 3: Division of Viral Diseases, The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329; 4: Department of Infectious Diseases, University of Virginia Health System, Charlottesville, VA; 5: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA; 6: Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL
-
Received 22 October 2015 Accepted 12 November 2015 Published 08 April 2016
- Correspondence: Anne Schuchat, [email protected]
- « Previous Article
- Table of Contents
- Next Article »

-
Abstract:
This article describes measles and measles vaccination, along with the challenges, successes, and progress in the postelimination era.
-
Citation: Schuchat A, Fiebelkorn A, Bellini W. 2016. Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era. Microbiol Spectrum 4(2):EI10-0006-2015. doi:10.1128/microbiolspec.EI10-0006-2015.




Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/microbiolspec/4/2/EI10-0006-2015-1.gif /docserver/preview/fulltext/microbiolspec/4/2/EI10-0006-2015-2.gif

References

Article metrics loading...
Abstract:
This article describes measles and measles vaccination, along with the challenges, successes, and progress in the postelimination era.

Full text loading...
Figures
Measles, United States, 1962 to 2014. (Adapted from reference 1 with permission.)

Click to view
FIGURE 1
Measles, United States, 1962 to 2014. (Adapted from reference 1 with permission.)
Measles virus-containing vaccine coverage among 19- to 35-month-olds (Immunization Information Survey, 1967 to 1985, and National Immunization Survey, 1994 to 2014 [ 17 ]) and among 13- to 17-year-olds (NIS-teen), ( 18 ) by year. (Adapted from references 17 , 18 with permission.)

Click to view
FIGURE 2
Measles virus-containing vaccine coverage among 19- to 35-month-olds (Immunization Information Survey, 1967 to 1985, and National Immunization Survey, 1994 to 2014 [ 17 ]) and among 13- to 17-year-olds (NIS-teen), ( 18 ) by year. (Adapted from references 17 , 18 with permission.)
Reported cases of measles by region of importation, 2001 to 2015. (Adapted from reference 20 with permission.)

Click to view
FIGURE 3
Reported cases of measles by region of importation, 2001 to 2015. (Adapted from reference 20 with permission.)
Map of imported measles cases, by state, 2001 to 2015. (Source, Division of Viral Diseases, CDC [ 51 ].)

Click to view
FIGURE 4
Map of imported measles cases, by state, 2001 to 2015. (Source, Division of Viral Diseases, CDC [ 51 ].)
Tables
Characteristics of recent outbreaks of measles in the United States with >20 cases a

Click to view
TABLE 1
Characteristics of recent outbreaks of measles in the United States with >20 cases a
Comparison of key variables from measles cases reported during 2001 to 2008 versus 2009 to 2014 a

Click to view
TABLE 2
Comparison of key variables from measles cases reported during 2001 to 2008 versus 2009 to 2014 a
Supplemental Material
No supplementary material available for this content.